Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHA:603139)

China · Delayed Price · Currency is CNY

30.07

-1.39 (-4.42%)

Jul 30, 2026, 3:00 PM CST

SHA:603139 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	443.29	471.29	561.63	672.96	491.51	442.76
Revenue Growth	-20.22%	-16.09%	-16.54%	36.92%	11.01%	6.93%
Gross Profit	90.68	88.69	155.73	183.75	188.49	200.88
Operating Income	-136.77	-135.4	-60.97	1.37	-8.17	18.27
Net Income	-295.33	-333.45	-89.63	-26.16	-63.06	36.48
Earnings Per Share	-2.97	-3.34	-0.90	-0.26	-0.63	0.37
EPS Growth	-	-	-	-	-	8.82%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Pharmaceutical Manufacturing	270.2
Pharmaceutical Distribution	173.71
Others	16.18
Offset of Business Segment	-0.65
Total	459.44

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	52.95	107.97	97.96	166.77	230.77	323.43
Total Debt	586.9	696.87	631.83	671.43	543.85	495.39
Net Cash (Debt)	-533.95	-588.9	-533.87	-504.66	-313.07	-171.97
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-5.37	-5.90	-5.36	-5.02	-3.13	-1.74

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	32.38	-16.72	37.29	-72.13	50.43	7.42
Capital Expenditures	-38.71	-15.53	-46.66	-72.38	-138.13	-290.3
Free Cash Flow	-6.32	-32.25	-9.37	-144.52	-87.7	-282.88
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	20.46%	18.82%	27.73%	27.30%	38.35%	45.37%
Operating Margin	-30.85%	-28.73%	-10.86%	0.20%	-1.66%	4.13%
Pretax Margin	-65.98%	-72.86%	-21.64%	-8.61%	-16.83%	8.72%
Profit Margin	-66.62%	-70.75%	-15.96%	-3.89%	-12.83%	8.24%
FCF Margin	-1.43%	-6.84%	-1.67%	-21.48%	-17.84%	-63.89%

Dividends

Fiscal Year	FY 2021
Period Ending	Dec '21 Dec 31, 2021
Dividend Per Share	0.074
Dividend Per Share Growth	5.71%
Dividend Yield	0.34%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	59.60
Forward PE	-	23.05	23.05	23.05	23.05	23.05
PS Ratio	7.09	4.34	2.55	2.79	3.61	4.91